Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.11 (
CD10
)
9,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Carotid body
(CB) contains multiple neurochemicals that include catecholamines (CA) and neuropeptides. They are involved in the modulation of sensory response of the carotid body. Based on observations from the central nervous system, we hypothesized that CA modulates neuropeptide metabolism in CB. To test our hypothesis, fetal calf carotid body model was used. Immunocytochemical analysis showed that fetal calf carotid body expresses both tyrosine hydroxylase, and
neutral endopeptidase
-like immunoreactivity. To assess the effect of CA, thin slices of fetal calf carotid body were incubated with 50-500 microM of dopamine (DA) at 37 degrees C for 1 hour. As an index of neuropeptide metabolism, the activity of
neutral endopeptidase
(
NEP
), a major degrading enzyme of neuropeptides in CB was determined in the membrane-enriched and soluble fractions of the carotid body. CBs incubated with medium lacking DA served as control. On average,
NEP
activities of the membrane-enriched, and soluble fractions of the untreated CB were 4.8 +/- 0.2 and 6.7 +/- 0.2 pmole per hour per mg of CB respectively. At concentrations less than 200 microM, DA enhanced
NEP
activity of the membrane fraction (approximately 60%) whereas inhibition of
NEP
was observed in the soluble fraction (approximately 62%). At concentrations > 200 microM, DA inhibited
NEP
activity of the two fractions. When CBs were incubated with DA in the presence of sodium dithionite, an oxygen scavenger, DA, even at higher concentrations, stimulated
NEP
activity of the membrane-enriched fraction. The above results demonstrate that DA modulates neuropeptide metabolism in CB via a non-receptor-mediated mechanism involving a direct interaction with
NEP
.
...
PMID:Interaction between catecholamines and neuropeptides in the carotid body: evidence for dopamine modulation of neutral endopeptidase activity. 1084 91
Carotid body
expresses
neutral endopeptidase
(
NEP
)-like enzyme activity and phosphoramidon, an inhibitor of
NEP
augments sensory response of the carotid body to hypoxia (Kumar et al., 1990).
NEP
hydrolyzes substance P (SP) and methionine enkephalin (Met-ENK) in the nervous system. In the present study, we determined whether
NEP
hydrolyzes Met-ENK and SP in the carotid body and whether these peptides contribute to the phosphoramidon-induced potentiation of the sensory response to hypoxia. Experiments were performed on carotid bodies excised from anaesthetized adult cats. HPLC analysis showed that both SP and Met-ENK were hydrolyzed by the carotid body. Phosphoramidon (400 microM) markedly inhibited SP (approximately 90%) but had only marginal effect on Met-ENK hydrolysis (approximately 15%). Sensory responses of the carotid body in vitro to hypoxia (pO2, 68 +/- 6 mmHg) and SP (10 nmoles) were potentiated by phosphoramidon by approximately 80% and approximately 275% respectively (p < 0.01). SP-receptor antagonist abolished phosphoramidon-induced potentiation of the sensory response to hypoxia as well as to SP. These results demonstrate that SP is a preferred substrate for
NEP
in the carotid body and SP plays a major role in the potentiation of the hypoxic response of the carotid body by phosphoramidon.
...
PMID:Role of substance P in neutral endopeptidase modulation of hypoxic response of the carotid body. 1084 12